维普中文期刊产品整合服务
16篇 您的检索式:作者名="Yardley V"
    题名 作者 年代 出处 被引量
1Formulation of amphotericin B as nanosuspension for oral administration显示文摘KAYSER O OLBRICH C YARDLEY V 2003Int J Pharm2003,254,1:1
2In vivo activity of farnesyl pyrophosphonate synthase inhibitors against Leishmania donovani and Toxoplasma gondii显示文摘Yardley V Khan AA Martin MB 2002Antimirob Agents Chemother2002,46,3:1
3A topical nitric oxide-generating therapy for cutaneous leishmanisis显示文摘Davidson RN Yardley V Croft SL 2000Trars R Soc Trop Med Hyg2000,94,3:1
4Formulation of amphotericin B as nanosuspension for oral administration显示文摘O Kayser C Olbrich V Yardley 2003Int J Pbarm2003,254,1:1
5Is sexual intercourse a significant cause of haematuria? 显示文摘Harris NM Yardley I Basketter V 2002BJU lntemational2002,89,4:1
6A topical nitric oxide-generating therapy for cutaneous leishmanisis显示文摘Davidson R Yardley V Croft S 2000Trars R Soc Trop Med Hyg2000,94,3:1
7Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal显示文摘DECUYPERE S RUAL S YARDLEY V 2005Antimicrobial A-gents and Chemotherapy2005,49,:1
8A topical nitric oxide-generating therapy for cutaneous leishmaniasis 显示文摘Davindson R N Yardley V Croft S L 2000Trans R Soc Trop Med Hyg2000,94,3:1
9A topical nitric oxide-generating therapy for cutaneous leishmaniasis显示文摘Davindson RN Yardley V Croft SL 2000Trans R Soc Trop Med Hyg2000,94,3:1
10Formulation of amphotericin B as nanosuspension for oral administration显示文摘Kayser O Olbrich C Yardley V 2003Int J Pharm2003,254,1:1
11Formulation of amphotericin B as nanosuspension for oral administration显示文摘Kayser O Olbrich C Yardley V 0,,:1
12A topical nitric oxide - generating therapy for cutaneous leishmaniasis 显示文摘Davidson RN Yardley V Croft SL 2000Trans R Soc Trop Med Hyg2000,94,3:1
13Randomized, phase II, placebo-controlled trial of onartuzumab and/or bevacizumab in combination with weekly paclitaxel in patients with metastatic triple-negative breast cancer 显示文摘Dieras V Campone M Yardley DA 2015Ann Oncol2015,26,9:1
14Formulation of ampho - tericin B as nanosuspension for oral administration 显示文摘Kayser O Olbrieh C Yardley V 2003Int J Pharm2003,254,1:1
15Formulation of Amphotericin B as Nanosuspension for Oral Administration 显示文摘Kaiser O Olbrich C Yardley V 2003Int J Pharm2003,254,:1
16Charge transfer on the nanoscale:current status显示文摘Adams D M Brus L Chidsey C E D Creager S Creutz C Kagan C R Kamat P V Lieberman M Lindsay S Marcus R A Metzger R M Michel-Beyerle M E Miller J R Newton M D Rolison D R Sankey O Schanze K S Yardley J Zhu X 0,,28:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费